Sandoz Group AG
SIX:SDZ
Intrinsic Value
Sandoz Group AG is a CH-based company operating in Pharmaceuticals industry. [ Read More ]
The intrinsic value of one SDZ stock under the Base Case scenario is 33.52 CHF. Compared to the current market price of 30 CHF, Sandoz Group AG is Undervalued by 10%.
Valuation Backtest
Sandoz Group AG
Run backtest to discover the historical profit from buying and selling SDZ stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Sandoz Group AG
Sandoz Group AG
Earnings Waterfall
Sandoz Group AG
Revenue
|
9.1B
USD
|
Cost of Revenue
|
-4.8B
USD
|
Gross Profit
|
4.3B
USD
|
Operating Expenses
|
-2.9B
USD
|
Operating Income
|
1.4B
USD
|
Other Expenses
|
-522m
USD
|
Net Income
|
848m
USD
|
Free Cash Flow Analysis
Sandoz Group AG
SDZ Profitability Score
Profitability Due Diligence
Sandoz Group AG's profitability score is 53/100. The higher the profitability score, the more profitable the company is.
Score
Sandoz Group AG's profitability score is 53/100. The higher the profitability score, the more profitable the company is.
SDZ Solvency Score
Solvency Due Diligence
Sandoz Group AG's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Score
Sandoz Group AG's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
SDZ Price Targets Summary
Sandoz Group AG
According to Wall Street analysts, the average 1-year price target for SDZ is 34.83 CHF with a low forecast of 26.26 CHF and a high forecast of 46.2 CHF.
Shareholder Return
SDZ Price
Sandoz Group AG
Average Annual Return |
N/A
|
Standard Deviation of Annual Returns |
N/A
|
Max Drawdown | -20% |
Market Capitalization | 12.9B CHF |
Shares Outstanding | 431 000 000 |
Percentage of Shares Shorted |
N/A
|
SDZ News
Last Important Events
Sandoz Group AG
Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.
Sentiment Analysis
Sandoz Group AG
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Sandoz Group AG is a CH-based company operating in Pharmaceuticals industry. The company is headquartered in Rotkreuz, Zug. The company went IPO on 2023-10-04. Sandoz Group AG is a Switzerland based company working in the healthcare technology field, the Company does this by operating in two segments, generics and biosimilar. Generic refers to drugs that is structurally equivalent to an original drug whose patent expired. Biosimilar refers to drugs, unlike generics that are equivalent, are slightly different from other approved reference biologics but has no clinically significant differences. The firm interacts in these fields, either directly or indirectly, by the buying and selling of intellectual property and other assets relating to generics and biosimilar drugs. The geographic scope of these investment can fall either domestically or internationally.
Contact
IPO
Employees
Officers
The intrinsic value of one SDZ stock under the Base Case scenario is 33.52 CHF.
Compared to the current market price of 30 CHF, Sandoz Group AG is Undervalued by 10%.